1. Home
  2. DGLY vs PRFX Comparison

DGLY vs PRFX Comparison

Compare DGLY & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digital Ally Inc.

DGLY

Digital Ally Inc.

HOLD

Current Price

$0.67

Market Cap

1.5M

Sector

Technology

ML Signal

HOLD

Logo PainReform Ltd.

PRFX

PainReform Ltd.

HOLD

Current Price

$0.67

Market Cap

1.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DGLY
PRFX
Founded
2004
2007
Country
United States
Israel
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5M
1.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
DGLY
PRFX
Price
$0.67
$0.67
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
105.3K
148.1K
Earning Date
12-29-2025
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$19,097,965.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$0.71
52 Week High
$1,320.00
$6.65

Technical Indicators

Market Signals
Indicator
DGLY
PRFX
Relative Strength Index (RSI) 26.86 29.68
Support Level $0.70 $0.81
Resistance Level $1.41 $0.91
Average True Range (ATR) 0.09 0.08
MACD -0.02 -0.02
Stochastic Oscillator 6.53 12.67

Price Performance

Historical Comparison
DGLY
PRFX

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

About PRFX PainReform Ltd.

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Share on Social Networks: